Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2019, Vol. 46 Issue (1): 113-117    DOI: 10.12891/ceog4519.2019
Original Research Previous articles | Next articles
Medical treatment as a possible treating modality for premalignant vulvar lesions
R. Zivadinovic1, 4, B. Zivadinovic2, 5, A. Petric1, 4, D. Krtinic3, 6, *(), S.P. Trajkovic Dinic1, 4
1 Department for Gynecology and Obstetrics, Faculty of Medicine, University of Nis, Nis, Serbia
2 Department for Neurology, Faculty of Medicine, University of Nis, Nis, Serbia
3 Department for Pharmacology and Toxicology, Faculty of Medicine, University of Nis, Nis, Serbia
4 Clinic for Gynecology and Obstetrics, Clinical Center Nis, Nis, Serbia
5 Clinic for Neurology, Clinical Center Nis, Nis, Serbia
6 Clinic for Oncology, Clinical Center Nis, Nis, Serbia
Download:  PDF(524KB)  ( 188 ) Full text   ( 4 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose of investigation: Purpose of this investigation was to determine the possibilities of non-surgical, medical treatment of highgrade squamous intraepithelial lesion (HSIL) of the vulva and differentiated type of vulvar intraepithelial lesions (VIN) and to determine the effect of medical treatment by local and systemic immunomodulators in relation to different histological types. Materials and Methods: The study included five patients with different histological types of VIN. The patients were given: systemic immunomodulator and antivirotics. After that, the patients initially included in the study were followed for a year, while the follow-up of the older patients group is still ongoing, and it has been six months since the completion of the treatment. Results: Combined medical therapy has positive therapeutic effect in the treatment of young HPV-positive adolescent patients with HSIL of the vulva. Medical treatment in HPV negative women with differentiated type VIN is less efficient, achieving partial remission in only 33% of patients. Conclusion: Combined medical therapy achieved better effects in hyperpigmented multifocal type of VIN.
Key words:  Medicals treatment      Vulvar intraepithelial neoplasia      Adolescence      Menopause      Premalignant lesions     
Published:  10 February 2019     
*Corresponding Author(s):  D. KRTINIC     E-mail:  dane.krtinic@medfak.ni.ac.rs

Cite this article: 

R. Zivadinovic, B. Zivadinovic, A. Petric, D. Krtinic, S.P. Trajkovic Dinic. Medical treatment as a possible treating modality for premalignant vulvar lesions. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 113-117.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4519.2019     OR     https://ceog.imrpress.com/EN/Y2019/V46/I1/113

[1] R. Tachibana, H. Matsushita, A. Minami, N. Morita, S. Shimizu, H. Kanazawa, T. Suzuki, K. Watanabe, A. Wakatsuki. Dietary sesame diminishes bone mass and bone formation indices in ovariectomized rats[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 546-551.
[2] F. N. Tuysuzoglu, G. A. Ilhan, B. Yildizhan. The impact of surgical menopause on metabolic syndrome, bone mineral density, and vasomotor symptoms[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 179-182.
[3] N. Morita, H. Matsushita, A. Minami, S. Shimizu, R. Tachibana, H. Kanazawa, T. Suzuki, K. Watanabe, A. Wakatsuki. Effect of the methanol extract of the Lion’s Mane mushroom, Hericium erinaceus, on bone metabolism in ovariectomized rats[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 47-52.
[4] J.D. Jaremek, D.R. Chinniah, A. Słopień, P. Rynio, R. Słopień. Menopausal depression - state of art[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 859-861.
[5] Lingping Zhu, Xing Chen, Wenpei Bai, Xiaoyan Yan. Factors associated with the quality of life in women with perimenopausal and postmenopausal status: a cross-sectional questionnaire survey from China[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 90-103.
[6] Jung Yeob Seoung, Suk Woo Lee, Young Mo Kang, Min Jung Kim, Jae Min Park, Hye Min Moon, Chae Chun Rhim. Association between metabolic risks and bone mineral density in postmenopausal women[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 671-676.
[7] R. Słopień, S. Khadka, M. Englert-Golon, M. Pisarska-Krawczyk, S. Sajdak. Is there a place for menopausal hormonal therapy in the treatment of postmenopausal osteoporosis?[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(3): 325-327.
[8] Ju-Qi Ma, Chun-Fen Guo, Ayshamgul Hasim. Clinical efficacy of levonorgestrel releasing intrauterine system for the treatment of adenomyosis in perimenopausal women[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(3): 387-390.
[9] Y.J. Lee, K.Y. Yun, S.C. Kim, J.K. Joo, K.S. Lee. The association between cystatin C and metabolic syndrome according to menopausal status in healthy Korean women[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(5): 716-720.
[10] G. Mainini, M. Passaro, R. Sgambato, M. Rotondi, L. Stradella, D. Labriola, D. Ambrosio, C. Stradella, M.T. Schettino, M. Torella. Phytoestrogens for menopausal vasomotor symptoms: efficacy of soybean isoflavones supplements for alleviating menopausal symptoms is positively related to hot flushes frequency[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 521-523.
[11] J. Brodowski, A. Jurczak, E. Grochans, B. Karakiewicz, M. Laszczyńska, S. Ciećwież, A. Włoszczak-Szubzda, A. Starczewski, A. Brodowska. Occurrence of climacteric symptoms in postmenopausal women after prophylactic bilateral ovariectomy[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(3): 403-407.
[12] M.M. Ianieri, D.I.P. Buca, P. Panaccio, M. Cieri, F. Francomano, M. Liberati. Retroperitoneal endometriosis in postmenopausal woman causing deep vein thrombosis: case report and review of the literature[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(1): 148-150.
No Suggested Reading articles found!